CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
ceftriaxone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00374959
NCT00374959Phase 4Completed
CompareCT.gov

The Prevention of Primary Endogenous Ventilator-Associated Pneumonia: A Multicenter Randomized Trial Comparing Continuous Aspiration of Subglottic Content and a 3-Day Course of Ceftriaxone.

Hospital Universitario Principe de Asturias·interventional·Posted Sep 12, 2006·Updated Sep 26, 2006

In Brief

A Phase 4 clinical trial evaluating ceftriaxone and Endotracheal tube for aspiration of subglottic secretions. for Pneumonia. Completed, across 3 sites.

Detailed Summary

The primary purpose of the trial is to compare the efficacy and safety of two measures which claim to prevent early-onset ventilator-associated pneumonia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesSpain
CollaboratorsHoffmann-La Roche

Timeline

Phase 4CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2006
Enrollment StartOct 1, 2000
Study CompletionOct 1, 2003
TodayJul 2, 2026
Posted 19.8 years ago

Interventions

ceftriaxonedrug

Endotracheal tube for aspiration of subglottic secretions.device